Shiseido, the Japanese cosmetics and pharmaceutical brand, has announced that it is to merge two of its subsidiaries. The aim? Strengthen the company’s growth and create new demand.
Japanese cosmetics company Shiseido has announced that its subsidiaries Shiseido Japan and Shiseido Pharmaceutical will merge at the end of the year.
The activities of Shiseido Pharmaceutical will be transferred to Shiseido Japan, which operates cosmetics and healthcare businesses in Japan. The operation will take the form of an absorption-type demerger.
The Shiseido Group, which reported a good first quarter, has set out its medium-term strategy, “SHIFT 2025 and Beyond”, under a new management structure. It intends to strengthen its growth to “be a global winner”, it states in a press release.
New opportunities
The company has targeted the -Clean ＆ Dermatology and -Inner Beauty fields, which continue to grow, as new growth opportunities to capture changes among Japanese consumers. Its pharmaceuticals unit has brands in these areas, which Shiseido Japan, which controls national marketing and sales operations, can build on.
Shiseido intends to create new demand and add value by strengthening initiatives in these areas.
Read also >Cosmetics: L’Oréal, Lvmh and Shiseido to buy Aesop
Featured photo : ©Press
